Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML (Journal of Hematology & Oncology, (2020), 13, 1, (132), 10.1186/s13045-020-00964-5)

Research output: Contribution to journalComment/debatepeer-review

Abstract

The original article [18] mistakenly contains duplicate references. The correct reference list can be viewed in this Correction article.

Original languageEnglish (US)
Article number34
JournalJournal of Hematology and Oncology
Volume14
Issue number1
DOIs
StatePublished - Dec 2021

ASJC Scopus subject areas

  • Hematology
  • Molecular Biology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML (Journal of Hematology & Oncology, (2020), 13, 1, (132), 10.1186/s13045-020-00964-5)'. Together they form a unique fingerprint.

Cite this